SiL Vascular

About

Q&A

What is SiL Vascular's primary focus?

SiL Vascular is a medical device company focused on developing an angioplasty double-balloon technology to advance the treatment of peripheral vascular disease.

When was SiL Vascular founded?

SiL Vascular was founded in October 2012.

What is the current status of SiL Vascular?

SiL Vascular is currently inactive, as of November 2018.

Where is SiL Vascular headquartered?

SiL Vascular is headquartered in Misgav Regional Council, Israel.

How many employees does SiL Vascular have?

SiL Vascular has 6 employees, falling within the 1-10 employee bucket.

What is the key technology developed by SiL Vascular?

SiL Vascular's system utilizes a short balloon moving within a long balloon, allowing physicians to inflate the long balloon to nominal pressure and then use the short balloon to target and open difficult-to-treat blockages.

Who is a co-founder and CTO of SiL Vascular?

Eyal Teichman is a Co-Founder and CTO of SiL Vascular.

What is SiL Vascular's current funding stage?

SiL Vascular is in the Pre-Funding stage.

Team · 1

Eyal Teichman

Founder · Co-Founder & CTO

LinkedIn ↗

Sectors & technology

Tags